NLRP3 and major depressive disorder: Overall, our study demonstrated the antidepressant effect of 4-MESC through the inhibition of NLRP3 inflammasome activation, suggesting the potential clinical use of 4-MESC in NLRP3 inflammasome-associated inflammatory diseases such as depression.